Alexander Strauss
Child & Adolescent Psychiatry · Marlton, NJNPI 1396946869
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations.
Across 98 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$163
- Sunovion Pharmaceuticals Inc.$139
- AbbVie$134
- Otsuka America Pharmaceutical, Inc.$131
- Tris Pharma Inc$111
- Vanda Pharmaceuticals Inc.$94
- plus $742 from 18 others
What the payments were for
- Food & beverage$1,514100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 11 | $163 |
| Sunovion Pharmaceuticals Inc. | 9 | $139 |
| AbbVie | 9 | $134 |
| Otsuka America Pharmaceutical, Inc. | 8 | $131 |
| Tris Pharma Inc | 7 | $111 |
| Vanda Pharmaceuticals Inc. | 6 | $94 |
| Lundbeck LLC | 6 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $87 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $86 |
| Bausch Health US, LLC | 4 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
| Alkermes, Inc. | 3 | $47 |
| Ironshore Pharmaceuticals Inc. | 3 | $42 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Harmony Biosciences LLC | 2 | $32 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Neurocrine Biosciences, Inc. | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
| Neuronetics, Inc. | 1 | $9 |
How this compares
$1,514 in reported general payments places this provider in the 80th percentile of 137 child & adolescent psychiatry providers in New Jersey.
See all child & adolescent psychiatry providers in New Jersey →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 11 | $1,533 |
| Clozapine | 24 | $642 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $168 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $130 |
| Mirtazapine | 13 | $88 |
| Lorazepam | 16 | $66 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Marlton
- Leonie PrinceMarlton$4K
- Ravinder BhallaRidgewood$125K
- Steven DyckmanEast Brunswick$53K
- Eric BartkyLivingston$51K
- Bohdan CzartoryskyParsippany$21K
- Akhtar HossainSomerville$19K
- Suzanne LindNew Brunswick$18K
- Aykut OzdenEdgewater$17K
- Valeria KorshunovaHackensack$12K
- Carol DobrzynskiBrick$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.